Dyne Therapeutics Inc
NASDAQ:DYN
Dyne Therapeutics Inc
NASDAQ:DYN
Price:
17.09
USD
-0.29%
Market Closed
Market Cap:
$2.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dyne Therapeutics Inc
NASDAQ:DYN
|
US |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
A
|
Adtec Plasma Technology Co Ltd
TSE:6668
|
JP |
|
Winmark Corp
NASDAQ:WINA
|
US |
|
Income Asset Management Group Ltd
ASX:IAM
|
AU |
|
Companhia Estadual de Distribuicao de Energia Eletrica CEEED
BOVESPA:CEED4
|
BR |
|
MSL Solutions Ltd
ASX:MSL
|
AU |
|
China Citic Bank Corp Ltd
SSE:601998
|
CN |
|
ABC-Mart Inc
TSE:2670
|
JP |
|
J
|
Jianzhong Construction Development Ltd
HKEX:589
|
CN |
|
Indiabulls Housing Finance Ltd
NSE:IBULHSGFIN
|
IN |
|
C
|
CD Projekt SA
WSE:CDR
|
PL |
|
Gfinity PLC
LSE:GFIN
|
UK |
|
E
|
EUROKAI GmbH & Co KgaA
F:EUK3
|
DE |
|
P
|
Petroleum Mechanical JSC
VN:PMS
|
VN |
|
G
|
Grupo Supervielle SA
BCBA:SUPV
|
AR |
|
Rocky Mountain Liquor Inc
XTSX:RUM
|
CA |
|
Zhejiang Chunhui Intelligent Control Co Ltd
SZSE:300943
|
CN |
|
P
|
Pangang Group Vanadium & Titanium Resources Co Ltd
SZSE:000629
|
CN |
|
Novorossiyskiy Kombinat Khleboproduktov PAO
MOEX:NKHP
|
RU |
|
Autel Intelligent Technology Corp Ltd
SSE:688208
|
CN |
|
EUDA Health Holdings Ltd
NASDAQ:EUDA
|
SG |
|
A
|
APact Co Ltd
KOSDAQ:200470
|
KR |
|
A
|
ADM Hamburg AG
F:OEL
|
DE |
Balance Sheet
Balance Sheet Decomposition
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet Decomposition is not available for
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Balance Sheet
Dyne Therapeutics Inc
Dyne Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
893
|
|
| Cash Equivalents |
8
|
15
|
301
|
201
|
172
|
122
|
435
|
893
|
|
| Short-Term Investments |
0
|
0
|
45
|
176
|
84
|
1
|
207
|
217
|
|
| Other Current Assets |
0
|
0
|
4
|
6
|
10
|
6
|
17
|
16
|
|
| Total Current Assets |
8
|
15
|
349
|
382
|
266
|
129
|
659
|
1 127
|
|
| PP&E Net |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
45
|
|
| PP&E Gross |
0
|
2
|
2
|
41
|
38
|
33
|
30
|
45
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
4
|
5
|
7
|
9
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
2
|
2
|
2
|
2
|
16
|
|
| Total Assets |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
1 187
+72%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
3
|
4
|
5
|
23
|
7
|
8
|
|
| Accrued Liabilities |
0
|
1
|
8
|
25
|
23
|
28
|
36
|
43
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
11
|
29
|
28
|
51
|
42
|
51
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
149
|
|
| Other Liabilities |
3
|
0
|
0
|
29
|
26
|
23
|
19
|
15
|
|
| Total Liabilities |
4
N/A
|
2
-41%
|
11
+358%
|
58
+423%
|
54
-6%
|
74
+37%
|
61
-17%
|
215
+250%
|
|
| Equity | |||||||||
| Common Stock |
9
|
27
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
5
|
20
|
79
|
229
|
397
|
633
|
950
|
1 396
|
|
| Additional Paid In Capital |
0
|
6
|
422
|
597
|
650
|
724
|
1 580
|
2 368
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
14
+233%
|
342
+2 346%
|
368
+8%
|
252
-31%
|
91
-64%
|
630
+590%
|
972
+54%
|
|
| Total Liabilities & Equity |
8
N/A
|
16
+98%
|
353
+2 054%
|
426
+20%
|
306
-28%
|
165
-46%
|
691
+319%
|
1 187
+72%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
44
|
44
|
45
|
52
|
56
|
61
|
102
|
165
|
|
Switch to:
Switch to:
See Also
Discover More
